Experts has a new look! Let us know what you think of the updates.

Provide feedback
Home
Scholarly Works
Lung Cancer–Related Clinical and Economic Impacts...
Journal article

Lung Cancer–Related Clinical and Economic Impacts of Achieving a 5% Smoking Prevalence Rate by 2035 in Canada

Abstract

Background: Smoking is responsible for nearly 85% of lung cancer cases and 30% of all cancer-related deaths. Canada has set an ambitious target to reduce tobacco use to 5% by 2035 in alignment with a world-wide tobacco endgame initiative. Aim: We project the impact of achieving a national 5% smoking prevalence rate by 2035 on population-level lung cancer outcomes and costs. Methods: OncoSim-Lung (version 2.5), led by the Canadian Partnership …

Authors

Gauvreau C; Fitzgerald N; Hussain S; Memon S; Flanagan W; Miller A; Goffin J; Evans W

Journal

Journal of Global Oncology, Vol. 4, No. Supplement 2, pp. 28s–28s

Publisher

American Society of Clinical Oncology (ASCO)

Publication Date

October 1, 2018

DOI

10.1200/jgo.18.27500

ISSN

2378-9506